Surrozen's competitors

Surrozen's competitors include Celldex Therapeutics, Intarcia Therapeutics, Visterra and Nosopharm
Add company...
Surrozen
A South San Francisco, CA-based biopharmaceutical company.
Celldex Therapeutics
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate.
Intarcia Therapeutics
Intarcia Therapeutics is a biopharmaceutical company developing therapies for diseases that require long-term chronic treatment.
Visterra
Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.
Nosopharm
Nosopharm is a biotechnology company dedicated to anti-infective drug discovery, targeting the bacterial multidrug resistance to antibiotics.
Founding Date
Founding Date
2016
Founding Date
1983
Founding Date
1997
Founding Date
2007
Founding Date
2009
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Hampton, US HQ
Branford, US
Fall River, US
Needham, US
Locations
Boston, US HQ
Hayward, US
Durham, US
Locations
Cambridge, US HQ
Locations
Nîmes, FR HQ
Employees
Employees
17 6% increase
Employees
205
Employees
411 1% decrease
Employees
67 5% increase
Employees
9
Valuation ($)
Valuation ($)
N/A
Valuation ($)
304.7 m
Valuation ($)
3.9 b
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
463
Twitter followers
52
Twitter followers
276

Funding

Latest funding round
Latest funding round
$ 33m (about 1 year ago)
Latest funding round
N/A
Latest funding round
$ 215m (over 1 year ago)
Latest funding round
$ 23.6m (5 months ago)
Latest funding round
$ 2.6m (11 months ago)
Total funding raised
Total funding raised
$ 33m
Total funding raised
N/A
Total funding raised
$ 1.9b
Total funding raised
$ 122.1m
Total funding raised
$ 3.8m
For sources of this data, please see the company profileDownload Excel

View company profiles